Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

CytoDyn Stock News

CYDYOTCQB

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$0.3158

0.01224.03%

At close: Dec 16, 4:00 PM EST

News

Insider Trades Short Interest

Latest CytoDyn Stock News | OTC:CYDY | Benzinga

Get the latest news on CytoDyn stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CytoDyn performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, May 28, 2025

A Penny Stock To Watch In Challenging Cancer Space
James Gornick

Tuesday, July 09, 2024

CytoDyn Settles With Amarex Clinical Research...
Benzinga Newsdesk

Thursday, February 01, 2024

CytoDyn Announces Submission Of Clinical Prot...
Benzinga Newsdesk

Monday, January 29, 2024

CytoDyn Appoints Jacob Lalezari As CEO, Effec...
Benzinga Newsdesk

Tuesday, January 17, 2023

Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
Jad Malaeb - Sponsored

Tuesday, December 13, 2022

OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
Jad Malaeb - Sponsored

Thursday, October 27, 2022

Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
Jad Malaeb - Sponsored

Tuesday, August 16, 2022

OTC Markets' Most Active Securities Sees A Shake-up In July
Jad Malaeb - Sponsored

Friday, August 05, 2022

These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
Chris Katje

Monday, July 18, 2022

Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
Jad Malaeb - Sponsored

Thursday, March 31, 2022

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Shanthi Rexaline

Monday, February 14, 2022

These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
Jad Malaeb - Sponsored

Monday, January 10, 2022

CytoDyn Highlights Research Paper 'Leronlimab (PRO 140) activity against 4-class drug resistant HIV-1 from Heavily Treatment Experienced Subjects' In ScienceDirect
Bill Haddad

Wednesday, December 29, 2021

Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
Dana Salzarulo - Sponsored

Friday, November 05, 2021

A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
Dana Salzarulo - Sponsored

Thursday, October 28, 2021

Is Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral?
Dana Salzarulo - Sponsored

Tuesday, October 12, 2021

These OTC Markets Securities had the Most Trading Activity in September
Austin Willson - Sponsored

Thursday, October 07, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Shanthi Rexaline

Friday, September 10, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Shanthi Rexaline

Wednesday, July 28, 2021

OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
Michael O'Connor - Sponsored

Tuesday, May 18, 2021

CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
Vandana Singh
CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
Vandana Singh
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Shanthi Rexaline

Wednesday, May 12, 2021

These OTC Securities Had the Most Trading Activity in April
Sean Sechler - Sponsored

Thursday, April 08, 2021

Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
Shanthi Rexaline

Saturday, March 20, 2021

FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
Shanthi Rexaline

Wednesday, March 17, 2021

Traders Demonstrate Enthusiasm For Emerging Sectors In February
Jaycee Tenn

Thursday, February 11, 2021

Traders Are Furiously Trading Companies In Emerging Industries
Jaycee Tenn

Monday, January 25, 2021

The Most Actively Traded Securities On OTC Markets In 2020 Included Cannabis, Crypto, And Multinationals
Spencer Israel

Tuesday, October 27, 2020

Traders Have Rotated Into Big Multinational Companies On OTC Markets
Spencer Israel

Tuesday, October 20, 2020

The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
Shanthi Rexaline

Wednesday, August 26, 2020

Senior Administration Official Says CytoDyn I...
Benzinga Newsdesk

Monday, August 17, 2020

These Were The Hottest Companies On OTC Markets In July
Spencer Israel

Friday, August 07, 2020

The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
Shanthi Rexaline

Monday, July 27, 2020

CytoDyn to Hold Conference Call on July 30 to Provide Updates on its Two COVID-19 Trials
Luke J Jacobi

Friday, July 24, 2020

Trading Activity In Emerging Names Increased On OTC Markets In June
Spencer Israel

Thursday, July 16, 2020

The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
Shanthi Rexaline

Wednesday, July 15, 2020

CytoDyn Reports Filing Of application For Nas...
Benzinga Newsdesk

Monday, July 06, 2020

HC Wainwright & Co. Downgrades CytoDyn to Neu...
Benzinga Newsdesk

Tuesday, June 16, 2020

Traders Had Cannabis And Transportation Companies On OTC Markets In Focus During May
Spencer Israel

Thursday, May 21, 2020

These Were The Most Active Securities On OTC Markets In April
Spencer Israel

Tuesday, May 05, 2020

'CytoDyn CEO made $12M from his stock sale, a...
Benzinga Newsdesk

Tuesday, April 28, 2020

HC Wainwright & Co. Reiterates Buy on CytoDyn...
Benzinga Newsdesk

Monday, April 20, 2020

How The COVID-19 Pandemic Could End
Tyree Gorges

Thursday, April 16, 2020

The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets
Spencer Israel

Friday, April 03, 2020

H.C. Wainwright Reiterates Buy on CytoDyn, Ra...
Benzinga Newsdesk

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Monday, March 09, 2020

Coronavirus Fears Spark The Heaviest Trading Month In Over A Year On OTC Markets
Spencer Israel

Monday, February 24, 2020

Dollar Volume In GBTC More Than Doubled In January, As Coronavirus Fears Spurred A Crypto Rally
Spencer Israel

Thursday, January 30, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved